Generation of XPA p.Arg228T mutant LUMCi004-A cell line for modeling Xeroderma pigmentosum group A.

Stem Cell Res

Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, Netherlands; The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, Netherlands; University of Grenoble Alpes, CEA, INSERM, IRIG, UA13 BGE, Biomics, Grenoble, France. Electronic address:

Published: December 2024

AI Article Synopsis

  • Xeroderma pigmentosum group A (XPA) is a genetic skin disorder that makes individuals highly sensitive to UV radiation, particularly impacting individuals of Maghrebi descent due to a specific mutation in the XPA gene.
  • The mutation (c.682C>T) results in a premature stop signal, and researchers used CRISPR/Cas9 gene editing to create a modified human induced pluripotent stem cell (hiPSC) line with this mutation.
  • The edited hiPSC line maintained normal characteristics and functionality, making it a useful model for studying XPA and its effects in a lab setting.

Article Abstract

Xeroderma pigmentosum group A (XPA) is an inherited skin disorder characterized by sensitivity to ultraviolet radiation. In Maghrebi patients, a homozygous mutation in exon 6 of the XPA gene (c.682C>T) results in the introduction of a premature termination codon. Using CRISPR/Cas9-mediated gene editing, this mutation was introduced into the well-characterized LUMCi004-A line. The resulting hiPSC line showed typical morphology, expressed markers of the undifferentiated state, was able to differentiate into the three germ layers in vitro and displayed a normal karyotype. When paired with its isogenic counterpart, this line represents a valuable resource to model the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2024.103564DOI Listing

Publication Analysis

Top Keywords

xeroderma pigmentosum
8
pigmentosum group
8
generation xpa
4
xpa parg228t
4
parg228t mutant
4
mutant lumci004-a
4
lumci004-a cell
4
cell modeling
4
modeling xeroderma
4
group xeroderma
4

Similar Publications

Transcription-coupled repair - mechanisms of action, regulation, and associated human disorders.

FEBS Lett

December 2024

Department of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8601, Japan.

The transcription-coupled repair (TCR) pathway resolves transcription-blocking DNA lesions to maintain cellular function and prevent transcriptional arrest. Stalled RNA polymerase II (RNAPII) triggers repair mechanisms, including RNAPII ubiquitination, which recruit UVSSA and TFIIH. Defects in TCR-associated genes cause disorders like Cockayne syndrome, UV-sensitive syndrome, xeroderma pigmentosum, and recently defined AMeDS.

View Article and Find Full Text PDF

Xeroderma pigmentosum (XP) disorder is recognized as a genetic condition inherited by autosomal recessive fashion. XP results from a defective DNA repair mechanism that significantly increases skin cancer risk. Fifteen Vietnamese patients were investigated with typical clinical manifestations of XP.

View Article and Find Full Text PDF

Beyond Huntington's Disease - Late-Onset Chorea Caused by a Homozygous Variant in ERCC4.

Cerebellum

December 2024

Division for Neurodegenerative Diseases, Department of Neurology, Universitaetsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.

Genetic alterations in the ERCC4 gene typically cause Xeroderma pigmentosum and other nucleotide excision repair disorders. Neurologic symptoms are present in some of these patients. In rare cases, ERCC4-mutations can manifest with prominent neurologic symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!